Form 4: Select Medical Director Marilyn Tavenner to Receive Restricted Stock Grant

Select Medical Holdings Corp. Director Marilyn B. Tavenner is set to receive a grant of 14,035 restricted common shares, vesting in July 2026.

Summary

• Marilyn B. Tavenner, a Director of Select Medical Holdings Corp (SEM), will be granted 14,035 shares of the company's common stock.
• The grant date for these restricted shares is July 29, 2025.
• The shares will vest in full on July 29, 2026, which is the first anniversary of the grant date, subject to certain exceptions.
• The acquisition price for these shares is $0, consistent with a restricted stock grant.
• Following this transaction, Ms. Tavenner's direct beneficial ownership of Select Medical Holdings Corp common stock will total 36,035 shares.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is a positive sign of alignment between management/board and shareholder interests, promoting long-term commitment. It's a standard compensation practice.

Positives

• The grant of restricted stock to a director aligns management and director interests with those of shareholders.
• The vesting schedule encourages long-term commitment and performance from the director.

Negatives

• The grant of restricted stock, while common, represents a form of compensation that can lead to minor dilution for existing shareholders over time.

Risks

• The restricted stock grant is subject to certain exceptions before vesting, which could impact the director's ability to fully realize the shares.

Corporate Governance

Related Party Transactions

• The grant of restricted stock to a director is a transaction between the company and a related party (an insider).

Stakeholder Impact

• Shareholders: Potential minor dilution from the issuance of new shares (though this is a grant, not an open market purchase), but improved alignment of director incentives with shareholder value.
• Director (Marilyn B. Tavenner): Receives equity compensation, increasing her stake and aligning her financial interests with the company's long-term performance.

Next Steps

• The restricted stock grant is scheduled to occur on July 29, 2025.
• The granted shares are expected to vest in full on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine restricted stock grant to a director, which is a standard component of executive compensation designed to align interests. It does not provide sufficient information on its own to warrant a change in investment recommendation, as it reflects an expected corporate governance practice rather than a significant operational or financial event. Investors should hold and consider this in the broader context of the company's overall performance and strategy.

Keywords

Select Medical Holdings Corp, SEM, Restricted Stock Grant, Form 4, Insider Transaction, Director Compensation, Equity Compensation, Corporate Governance, Marilyn B. Tavenner